Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Vildagliptin and Glimepiride on Glycemic Variability in Type 2 Diabetes
NCT01812122Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2013
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of vildagliptin and glimepiride in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Glycemic variability index at 6 months and Cardiovascular disease risk factor at 6 months. Started Mar 2013; status: completed.
02
Drugs
vildagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01812122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812122.